Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Support the BRAIN Initiative, but don’t overlook the neurogenomic diagnostics that are already driving breakthroughs in brain and rare neurological disorders.
Scientists create nontoxic pH nanosensors to assess viability of transplanted therapeutic cells.
Researchers can identify individuals by the unique chemical signatures in their breath, suggesting that exhalations could be used for metabolomic tests.
Next-generation sequencing diagnostics are already being used, and patients are ready.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.
Affordable diagnostic tests tackle the world’s most pressing health problems.
Researchers are getting closer to detecting abnormal tumor DNA circulating in the bloodstream.
The tenderness of cancer cells squeezed by a special apparatus can help pinpoint the ones most likely to spread the disease.